BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2024 3:29:42 AM | Browse: 45 | Download: 177
 |
Received |
|
2024-06-28 19:23 |
|
Peer-Review Started |
|
2024-06-28 19:23 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-08-04 07:04 |
|
Revised |
|
2024-08-08 21:55 |
|
Second Decision |
|
2024-08-20 02:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-08-20 08:58 |
|
Articles in Press |
|
2024-08-20 08:58 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-08-27 12:02 |
|
Typeset the Manuscript |
|
2024-08-30 02:11 |
|
Publish the Manuscript Online |
|
2024-09-12 03:29 |
| ISSN |
1948-5190 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
How secure can we expect the surveillance policies to be after the implementation in T1 polyps with carcinoma?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Cristina Mateos Sanchez, Elvira Quintanilla Lazaro and Luis Ramon Rabago |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Luis Ramon Rabago, MD, PhD, Chief Physician, Department of Gastroenterology, San Rafael Hospital, Street Serrano 199, Madrid 28016, Spain. lrabagot@gmail.com |
| Key Words |
pT1 adenocarcinoma polyps; pT1 follow up management; Histological recurrence rate of pT1 adenocarcinoma; Endoscopic and histologic poor prognostic criteria |
| Core Tip |
The management of endoscopically benign polyps that histopathologically prove to contain pT1 adenocarcinoma is not defined, pending international definition of the required resection and histological criteria to be able to rely on a follow-up without surgery. Based on Fabian's study, it is very likely that the rate of complete resection and the risk of recurrence is much higher than previously published and that we must also consider the risk of insufficient therapy. The follow-up of these patients remains to be clarified and agreed upon in multicenter studies that will make it possible to obtain more data at least for clinical practice and, above all, to insist on the potential risk for survival when patients are lost in follow-up programs. |
| Publish Date |
2024-09-12 03:29 |
| Citation |
<p>Mateos Sanchez C, Quintanilla Lazaro E, Rabago LR. How secure can we expect the surveillance policies to be after the implementation in T1 polyps with carcinoma? <i>World J Gastrointest Endosc</i> 2024; 16(9): 502-508</p> |
| URL |
https://www.wjgnet.com/1948-5190/full/v16/i9/502.htm |
| DOI |
https://dx.doi.org/10.4253/wjge.v16.i9.502 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
